More recently, Chan et al. [37] showed that steatotic HCC were associated with higher metabolic risk (diabetes, arterial hypertension, steatohepatitis), smaller tumor size, lower frequency of major vessel and microvascular invasion, earlier tumor stages and lower serum AFP. This evidence concerns the gene AFP and Hypertension.